Skip to main content
. 2018 Apr 20;9(30):21313–21321. doi: 10.18632/oncotarget.25092

Figure 1. The change of serum lipid levels in baseline and after 6 months of antiviral treatment.

Figure 1

Comparison of serum (a) triglycerides, (b) cholesterol, (c) high density lipoprotein cholesterol and (d) low density lipoprotein cholesterol levels in baseline and after 6 months of antiviral treatment stratified by sustained virologic response. Comparison of serum (e) triglycerides, (f) cholesterol, (g) high density lipoprotein cholesterol and (h) low density lipoprotein cholesterol levels in baseline and after 6 months of antiviral treatment stratified by FIB4 (cut-off point 3.25).